OBJECTIVES: Evaluate effects of a multicomponent intervention (human papillomavirus [HPV] vaccine-specific brochure and recalls) on HPV vaccination and secondarily examine if race/ethnicity moderates effects. METHODS:Unvaccinated girls aged 11 to 18 years attending 4 safety-net pediatric clinics and their parent/guardian (n = 814 dyads) were randomized to (1) active comparison (general adolescent vaccine brochure), or (2) intervention consisting of a HPV vaccine-specific brochure, telephone recalls to parents who declined, and recalls to patients overdue for doses 2 and 3. HPV 1-dose and 3-dose coverages were assessed via electronic health records 12 months after randomization. Multivariate logistic regressions estimated adjusted odds and marginal predicted vaccine coverage by study arm and race/ethnicity. RESULTS: Intent-to-treat analyses found no main effect of the HPV vaccine-specific brochure on 1-dose coverage (42.0% vs 40.6%); however, secondary analyses found race/ethnicity was a significant moderator such that the intervention was effective only for Hispanic individuals (adjusted odds ratio [AOR] 1.43; 95% confidence interval [CI] 1.02-2.02), and not effective for black individuals (AOR 0.64; 95% CI 0.41-1.13). Recalls to parents who declined the vaccine during the index visit were not effective, but recalls to patients overdue for doses 2 and 3 were effective at increasing 3-dose coverage regardless of race/ethnicity (AOR 1.99; 95% CI 1.16-3.45). CONCLUSIONS: Educational materials describing only the HPV vaccine were effective for Hispanic but not black individuals. Future research should test mechanisms that may mediate intervention effects for different racial/ethnic groups, such as different informational needs or vaccine schemas (experiences, beliefs, norms).
RCT Entities:
OBJECTIVES: Evaluate effects of a multicomponent intervention (human papillomavirus [HPV] vaccine-specific brochure and recalls) on HPV vaccination and secondarily examine if race/ethnicity moderates effects. METHODS: Unvaccinated girls aged 11 to 18 years attending 4 safety-net pediatric clinics and their parent/guardian (n = 814 dyads) were randomized to (1) active comparison (general adolescent vaccine brochure), or (2) intervention consisting of a HPV vaccine-specific brochure, telephone recalls to parents who declined, and recalls to patients overdue for doses 2 and 3. HPV 1-dose and 3-dose coverages were assessed via electronic health records 12 months after randomization. Multivariate logistic regressions estimated adjusted odds and marginal predicted vaccine coverage by study arm and race/ethnicity. RESULTS: Intent-to-treat analyses found no main effect of the HPV vaccine-specific brochure on 1-dose coverage (42.0% vs 40.6%); however, secondary analyses found race/ethnicity was a significant moderator such that the intervention was effective only for Hispanic individuals (adjusted odds ratio [AOR] 1.43; 95% confidence interval [CI] 1.02-2.02), and not effective for black individuals (AOR 0.64; 95% CI 0.41-1.13). Recalls to parents who declined the vaccine during the index visit were not effective, but recalls to patients overdue for doses 2 and 3 were effective at increasing 3-dose coverage regardless of race/ethnicity (AOR 1.99; 95% CI 1.16-3.45). CONCLUSIONS: Educational materials describing only the HPV vaccine were effective for Hispanic but not black individuals. Future research should test mechanisms that may mediate intervention effects for different racial/ethnic groups, such as different informational needs or vaccine schemas (experiences, beliefs, norms).
Authors: P A Briss; L E Rodewald; A R Hinman; A M Shefer; R A Strikas; R R Bernier; V G Carande-Kulis; H R Yusuf; S M Ndiaye; S M Williams Journal: Am J Prev Med Date: 2000-01 Impact factor: 5.043
Authors: Cynthia M Rand; Sharon G Humiston; Stanley J Schaffer; Christina S Albertin; Laura P Shone; Aaron K Blumkin; Shannon Stokley; Peter G Szilagyi Journal: Vaccine Date: 2011-08-12 Impact factor: 3.641
Authors: T C Davis; D D Fredrickson; C L Arnold; J T Cross; S G Humiston; K W Green; J A Bocchini Journal: Pediatrics Date: 2001-02 Impact factor: 7.124
Authors: Jasmin A Tiro; Sandi L Pruitt; Corinne M Bruce; Donna Persaud; May Lau; Sally W Vernon; Jay Morrow; Celette Sugg Skinner Journal: Vaccine Date: 2011-11-21 Impact factor: 3.641
Authors: Brenda Cassidy; Betty Braxter; Denise Charron-Prochownik; Elizabeth A Schlenk Journal: J Pediatr Health Care Date: 2013-03-20 Impact factor: 1.812
Authors: Christina A Suh; Alison Saville; Matthew F Daley; Judith E Glazner; Jennifer Barrow; Shannon Stokley; Fran Dong; Brenda Beaty; L Miriam Dickinson; Allison Kempe Journal: Pediatrics Date: 2012-05-07 Impact factor: 7.124
Authors: L Aubree Shay; Richard L Street; Austin S Baldwin; Emily G Marks; Simon Craddock Lee; Robin T Higashi; Celette Sugg Skinner; Sobha Fuller; Donna Persaud; Jasmin A Tiro Journal: Patient Educ Couns Date: 2016-06-25
Authors: Richard K Zimmerman; Krissy K Moehling; Chyongchiou J Lin; Song Zhang; Jonathan M Raviotta; Evelyn C Reis; Sharon G Humiston; Mary Patricia Nowalk Journal: Vaccine Date: 2016-11-18 Impact factor: 3.641
Authors: Mary A Gerend; Yesenia P Stephens; Michelle M Kazmer; Elizabeth H Slate; Elena Reyes Journal: J Adolesc Health Date: 2019-02-15 Impact factor: 5.012
Authors: Julie H T Dang; Susan L Stewart; Dean A Blumberg; Hector P Rodriguez; Moon S Chen Journal: Hum Vaccin Immunother Date: 2020-02-12 Impact factor: 3.452
Authors: Julie C Jacobson Vann; Robert M Jacobson; Tamera Coyne-Beasley; Josephine K Asafu-Adjei; Peter G Szilagyi Journal: Cochrane Database Syst Rev Date: 2018-01-18
Authors: Jasmin A Tiro; Simon Craddock Lee; Emily G Marks; Donna Persaud; Celette Sugg Skinner; Richard L Street; Deborah J Wiebe; David Farrell; Wendy Pechero Bishop; Sobha Fuller; Austin S Baldwin Journal: JMIR Res Protoc Date: 2016-01-29
Authors: Anna Acampora; Adriano Grossi; Andrea Barbara; Vittoria Colamesta; Francesco Andrea Causio; Giovanna Elisa Calabrò; Stefania Boccia; Chiara de Waure Journal: Int J Environ Res Public Health Date: 2020-10-30 Impact factor: 3.390